Two stocks for your watchlist
Montgomery Investment Management
Your gateway to investing in high-quality companies in Australia, New Zealand and around the globe.
In this edition of Montgomery’s newsletter, we discuss two holdings in our portfolios. Roger Montgomery shares the investment thesis behind a recent addition to The Montgomery Fund, AMP. And Gary Rollo speaks to Symbio Holding’s CEO and Co-Founder to discuss the business and their growth prospects.
If you enjoy the newsletter, you might like to view our blog which publishes daily content,?you can register for free full content access via our registration page.
IS AMP AN IMPROVING QUALITY COMPANY WITH A STRONG VALUATION CASE?
One new addition in The Montgomery Fund is AMP Limited (ASX:AMP), and on first mention this might seem like a controversial inclusion, but is it really? Roger states AMP is a company that would not meet most investor’s definition of quality. But to write it off, based on its historical performance, would be to potentially miss the future value being created. Is the share price yet to acknowledge the turnaround and improvement in quality now underway?
WHY SYMBIO SEES A LONG GROWTH STORY IN THE ASIAN MARKET
Listing on the ASX in 2006, Symbio (ASX:SYM) is an Australian software business that provides the glue for other software companies to access the telephone network. The company has been around for 20 years and they have recently embarked on an expanded strategy to move their product set into some key digital markets in Asia. Meet Symbio’s CEO and Co-Founder in this video and learn more about why it’s a holding in the Montgomery Small Companies Fund.